The 14th Annual Conference of Egyptian Society of Updates in Hepatology

and Gastroenterology With Egyptian Society of NASH and its Complication

Main Title : Second International Forum on Hepatitis

Cairo, Grand Nile Tower, Feb. 1-2 , 2017

-------------------------------------------------------------------------------

-

Scientific Program

SECOND INTERNATIONAL FORUM ON HEPATITIS

( Where are we from HCV Eradication )

UNDER THE PARTONAGE OF HIS EXCELLENCY PROF. AHMED EMAD Al Din

MINISTER OF HEALTH AND POPULATION

IN COLLABORATION WITH GENERAL AUTHORITY OF EDUCATIONAL INSITITUTES AND HOSPITALS

MILITARY MEDICAL ACADEMY

MEDICAL AFFIARS OF THE MINISTERY OF INTERIOR EGYPTIAN UNIVERSITIES AND RESEARCH INSTITUTES

Honorary President:

Profs. Ahmed El Garem,

Helmy Abaza, Samir

Kabeel, Sherif Abdel Fattah President:

Prof. Hosny Salama ________________________

International and Media

Activities :

Prof. Nadia Badawy .

Organizing Committee

President:

Prof. Eman Medhat,

Hassan Hamdy

Forum Board :

Prof. Hosny Salama

Prof. Omar Heikal

Prof. Asem El Sherif

Prof. Abdel Hamid Serwah

Prof.Sherif Abdel Fattah

Prof. Hany Nasr

Prof. Mohamed El Ateek

Prof. Hesham El Khayat

Prof. Mostafa Gabr

Prof. Hassan Hamdy

Prof. Eman Medhat

Prof. Abdel Rahman Zekri

Prof. Alaa El Mahdy

Treasurer :

Prof. Tarek Kaddah Forum Egyptian Board

Prof. Ahmed El-Garem

Prof. A. Raouf Abul- Azem

Prof. Ahmed Medhat Nasr

Prof. Osman Mahmoud

Prof. Mahmoud Osman

Prof. Ahmed El Tawdi

Prof. Bahaa Abbas

Prof. Ebrahiem Mostafa

Prof. Gamal Esmat

Prof. Sherif Megawer

Prof. Helmy Abaza

Prof. Mohsen Salama

Prof. Abdel Hamid Abaza

Prof. Eman Rowisha

Prof. Mohamed Amin Sakr

Prof. Mamdouh Gabr

Prof. Ayman Yousry

Prof. Moh. Sharaf Al Din

Prof. Medhat El-Sahhar

Prof. Alaa Nouh

Prof. Manal Hamdy El Sayed

Prof. Mohamed Ezz El-Arab

Prof. Mohamed Kamal shaker

Prof. Tawheida Abdel Ghaffar

Prof. Ahmed Shaarawy

Prof. Reda El-Wakil

Prof. Seham Abdel Rahim

Prof. Sahar Maklad

Prof. Yousry Taher

Prof. Ali Al Kady

Prof. Abdel Fattah Hanu

Prof. Mahmoud Bendary

Prof. Medhat Al Hosary

Scientific Program Wednesday, 1st February 2017 08:30-09:30 Registration

09:30-10:00 Opening Ceremony

10:00-10:30 Guest Lecture I

10:00-10:10 Memorial Lecture for Prof. M. Farid Abdel Wahab

by Prof. Ashraf Omar

10:10-10:30 Molecular and Clinical Bases of Anti-HCV Drug Resistance

Prof. George Y. Wu, M.D., Ph.D, USA.

Chairpersons : (Alphabetical)

Prof. Ahmed El Garem

Prof. Ahmed El Tawdy

Prof. Hany Nasr

Prof. Mohamed Ramadan Baddar

Prof. Mohamed Al- Ateek

Prof. Mostafa Al -Awady

Wednesday, 1st February 2017

10.30-11.30 Session I Molecular Biology of HCV

Moderator:

Prof. Abdel Rahman Zekri

Prof. Mostafa Al Awady

Chairpersons: (Alphabetical)

Prof. Abul Dahab Al-Sahly

Prof. Adel Al Rakeeb

Prof. Hesham A.K. Ayoub

Prof. Mervat Al-Ansary

Prof. Mona Shehata

Prof. Serag Zakaria

Speakers :

10:30-10:50 Function and structure of HCV-NS5A: The role of resistance

associated variance/ substitutions in resistance to Daclatasvir and

Ledipasvir

Prof. Mostafa K. El Awady ( National Research Center)

10:50-11:10 Diagnostic and prognostic values of HCV PBMC`s PCR in naïve

and experienced patients

Prof. Mohamed Darwish (Al Azhar University)

11:10-11:30 Possible correlation of HLA and severity of liver disease in HCV

infected patients

Prof. Abdel Rahman N. Zekri ( National Cancer Institute )

Wednesday, 1st February 2017

11:30-12:30 Session II HCV Epidemiology – Prevention and Control Worldwide and in Egypt

Moderator :

Prof. Amr Kandeel

Prof. Mohamed Al-Ateek

Chairpersons : (Alphabetical)

Prof. Abdel Fattah Hanno

Prof. Abdel Hamid Serwah

Prof. Mahmoud Othman

Prof. Maisa Shawky

Prof. Moataz Seyam

Prof. Sohier Zakaria

Prof. Taher Al-Demerdash

Speakers :

11:30-11:40 Ethics in conducting a community medical surveys

Prof. Azza Saleh

11:40-11:50 Eradication of HCV : A long way to go

Prof. Ahmed Hamid Serwah

11:50-12:00 Prevalence of HCV Worldwide and in Egypt past &future

Prof. Mohamed Al-Ateek

12:00-12.10 Genetic epedemiology of intra-familial transmission of HCV in Upper

o and lower Egypt. Prof. Mahmoud Al Bendary

12:10-12:20 Health education spots for Hepatitis C

Dr. Sherif Esam Al Din

12:20-12:25 Experience of disseminating prevention of HCV. Community based

approach. Prof. Maisa Shawky

12:25-12:30 Remarks on HCV control measures in Egypt

Prof. A. Hamid Abaza

Wednesday, 1st February 2017

12:30-01:00 Habib Scientific Office Symposium

Chairpersons : (Alphabetical)

Prof. Ahmed Shawky

Prof. Alaa Al Mahdy

Prof. Hasan El-Garim

Prof. Ibrahim Mostafa

Prof. Nabil Al Kady

Prof. Yehia Al Shazly

Prof. Zakaria Salama

Speakers:

Sof & Dacla with fixed dose versus wt. adjusted dose in treating HCV among

Egyptian patients

Prof. Hosny Salama

01:00-01:30 Guest lecture II

Chairpersons: (Alphabetical)

Prof. Ahmed El Garem

Prof. Ahmed Gomaa Prof. Ali Waheeb

Prof. Hussien Khallaf

Prof. Nadia Elwan

Speakers:

Towards an HCV-free generation Prof. Raymond Schinazi USA

01:30-02:00 Coffee Break

Wednesday, 1st February 2017

02:00-03:00 Session IV

Best of AASLD 2016

Moderator :

Prof. Sherif Abdel Fattah

Prof. Hosny Salama

Chairpersons : (Alphabetical)

Prof. Abdel-Kader Farrag

Prof. Alession Aghemo

Prof. Bahaa Abbas

Prof. Medhat Al-Sahhar

Prof. R. Schinazi

Prof. Seham A. Rahim

Prof. Taher El -Zanati

Speakers :

02:00-02:15 Prof. Magdy Al-Serafy for HCV

02:15-02:30 Prof. Ayman Yousry for HBV

02:30-02:45 Prof. Hesham El-Khayyat for NASH

02:45-03:00 Prof. Ashraf Omar for HCC

Wednesday, 1st February 2017

03:00- 05:30 Session V

HCV – Special population

Modertor :

Prof. Yousry Taher

Prof. Hosam A. Aziz

Chairpersons: (Alphabetical)

Prof. Amani Lashin

Prof. Ehab A. Khalik

Prof. George Wu

Prof. Hegzy M. Hegazy

Prof. Helmy Abaza

Prof. Mohamed Azab

Prof. Nahla Al-Gammal

Prof. Seham A. Rahim

Speakers:

03:00-03:10 HCV treatment in renal impairement patients

Dr. Mohamed Ata Allah

03:10- 03:20 HCV treatment in decompensated cirrhotic patients

Dr. Sahar Mohamed

03:20-03:30 HCV treatment in post liver transplantation patients

Dr. Mohamed Abdel Wahab

03:30-03:40 HIV-HCV co-infected patients treatment

Dr. Samah Abdel Hafez

03:40-03:50 HBV-HCV co-infected patients treatment

Dr. Lamiaa Mubarak

03:50- 04:00 HCV with extra-hepatic manifestations treatment

Dr. Mai Mehrez

04:00-04:10 DAAs in Management of HCV in Children and Adolescents: Is the

Jury Still Out?"

Prof. Mortada Al Shabrawy

Dr. Mostafa Yacout

04:10-04:20 For HCV relapsers and mutation, What is the role of available and

future drugs

Prof. Hassan Hamdy

04:20-04:30 Persistance of HCV RNA after SVR with DAAs treatment

Prof. Medhat Al-Hosary

04:30-04:45 Real world studies with approved HCV drugs

Prof. Yousry Taher

04:45-05:00 Real life experience in treating HCV at MLI

Prof. Eman Reweished

05:00 Lunch

Thursday 2nd February 2017:

09.30- 11.00 Session V

Guidelines in HCV treatment

Moderators :

Prof. Hesham Al Khayatt

Prof. Omar Heikal

Chairpersons : (Alphabetical)

Prof. Alaa Osman

Prof. Asem Al Sherif

Prof. Alessio Aghemo

Prof. Ali Farag

Prof. Hosny Salama

Prof. Sahar Maklad

Prof. Sherif Megawer

Speakers:

09:30-09:45 Egyptian guidelines on HCV treatment.

Prof. Omar Heikal

09:45-10:00 Treatment of special population HBV&HCV

Prof. Medhat El –Sahhar

10:00-10:15 Real life experience in treatment of decompensated liver cirrhosis

Prof. Mohsen Salama

10:15-10:30 Retreatment of relapser of DAAs failures

Prof. Hesham Elkayat

10:30-10:45 Treatment of HCV by DAAs in liver transplantation

Prof. Ashraf Omar

10:45-11:00 Elevated liver enzymes HCV clearance

Prof. Eman Medhat

Thursday 2nd February 2017:

11:00-11:30 Guest Lecture III ( Memorial Lecture Prof. A. Rahman El Zayadi- Presented by Prof. Hassan Hamdy )

Chairpersons : (Alphabetical)

Prof. Ahmed El Garem

Prof. Esmat Sheiba

Prof. Mohamed Makhlouf

Prof. Nadia Elwani

Prof. Seham Abdel Rahim

Prof. Shokry Hunter

Speakers:

HCV therapy: From Guidelines to elimination

Prof. Alessio Aghemo (Milan Italy)

Thursday 2nd February 2017:

11:30-12:00 AUG Symposium

Chairpersons : (Alphabetical)

Prof. Ahmed Shaarawy

Prof. Ali Al Kady

Prof. Amr Fateen

Prof. Nooman Al Garem

Prof. Osman A. Hamid Prof. Reda Al Wakil

Speakers:

Real World experience in using Sim-Sof for treating HCV , genotype 4 in Egypt .

Prof. Hesham El Khayatt

12:00-12:30 Coffee Break

Thursday 2nd February 2017

12:30- 02:30 Session VI NAFLD-NASH , Diabetes and HCV Infection

Moderator :

Prof. Eman Medhat

Prof. Hassan Hamdy

Chairpersons : (Alphabetical)

Prof. Prof. Ahmed Gomaa

Prof. Ahmed Khalik Hamed

Prof. Alaa Nouh

Prof. R. Schinazi

Prof. Said Mostafa

Prof. Taher Al-Zanaty

Speakers:

12:30-12:45 Epidemiology of NAFLD with special emphasis to associated HCV

and / or diabetes

Dr. Ahmed Khairy

12:45-01:00 Pathology spectrum of NAFLD

Prof. Hany Khattab Prof. Amal Hareidi

01:00-01:15 Diagnosis of NAFLD.-NASH spectrum

Dr. Ahmed Ramadan

01:15-01:30 NAFLD and HCV and steatosis : Pathogenesis.

Dr. Sherif Musa

01:30-01:45 Recent Trends in The treatment of NAFLD. -NASH and the

associated Diabetes

Prof. Eman Medhat

01:45-02:00 NAFLD and HCC relationship

Dr. Yasmin Gaber

02:00-02:15 Does treatment of HCV affect the diabetic state and vice versa

Prof. Hosny Salama

02:15-02:30 Morbidity assessment between steatosis , DM and HCV

before and after DAAs

Prof. Abdel Khalik Hamed

Thursday 2nd February 2017

02:30-04:30 Session VII Debate About HCC in the era of DAAs

Moderators :

Prof. Ashraf Omar

Prof. Mohamed Ezz Al Arab

Chairpersons : (Alphabetical)

Prof. Ahmed El Sawy

Prof. Amr Helmy

Prof. Laila Ahmed

Prof. Mohamed K. Shaker

Prof. Mohamed Tawfik

Prof. Samir Kabeel

Speakers:

02:30-02:45 Remarks on HCV, DAAs and HCC

Prof. Helmy Abaza

02:45-03:00 HCC recurrence after DAAs ,is it fact or fiction?

Prof. Mohamed A. Ezz el-Arab

03:00-03:15 Next Generation as tool to understand the underlining mechanics

in hepatocarcinogenesis

Prof. Ahmed Rahman Zekri

03:15-03:30 Immune system as initiator and terminator for HCC

Prof. Hosny Salama

03:30-04:00 Survival and prognostic factors for HCC, an Egyptian

multidisciplinary clinical experience

Prof. Asharf Omar Prof. Mohahmed Mahmoud

04:00-04:15 Giant HCC: is there a chance for cure? BCLC : is still satisfying to

follow ?

Prof. Mohamed Al –Warraky

04:15-04:30 HCV-HCC treat and treat or wait and treat

Prof. Ashraf El-Breedy

Thursday 2nd February 2017

04:30-06:00 Session VIII

Miscellaneous

Moderator :

Prof. Asem Al Sherif

Prof. Ayman Yousry

Chairpersons : (Alphabetical)

Prof. Alaa Othman

Prof. Amr Fateen

Prof. Mamdouh Gabr

Prof. Moataz Seyam

Prof. Nooman Al Garem

Prof. Walaa Fouad

Speakers:

04:30-04:40 HBV and Pregnancy: Optimal Management

Prof. Sami Zaki

04:40-04:50 Acute on chronic liver diseases .

Prof. Mahmoud El-Bendary

04:50-05:00 Early and late anamenestic response to Hepatitis B vaccine Booster

dose among vaccinated Egyptian children ages up to 16 years

Prof. Iman I. Salama

05:00-05:10 Vitamin D supplement Improve sustained virological response in

Chronic Hepatitis C (Genotype 4) Naive Patients Treated with

Pegylated Interferon and Ribavirin

Prof. Maisa Al-Raziky

05:10-05:20 DAAs after Liver Transplantation

Prof. Magdy Al-Dahshan

05:20-05:30 HCV, HBV, HIV co-infection .

Prof. Rabab Fouad

05:30-05:40 Pharmacokinetics of Sofosbuvir and its clinical application

Prof. Mohamed Sharaf Al Din

05:40-05:50 Endoscopic pariatric ttt GERD in NASH patients

Prof. Ayman A. Aziz

06:00-06:30 Media and NGO meeting - Closing Session &

Recommendations

06:30- 08:00 Lunch